Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
UCLA Clinical Genomics Center, |
RCV000200078 | SCV000255504 | likely pathogenic | Usher syndrome type 2A | 2013-04-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001388624 | SCV001589695 | pathogenic | not provided | 2020-03-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser3276*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with deafness (PMID: 25326637). ClinVar contains an entry for this variant (Variation ID: 217027). Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV000200078 | SCV004182648 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004816341 | SCV005072123 | likely pathogenic | Retinal dystrophy | 2012-01-01 | criteria provided, single submitter | clinical testing |